Product Directory — Diagnostics, Devices & Equipment


Refine by Category
Refine by Company

Showing Products For: All

Select Page
Burdick® 8300 ECG by Cardiac Science™ CARDIAC SCIENCE
The Burdick® 8300 ECG is a practical, no-nonsense ECG device. Its friendly user interface and clear, readable 5.7-inch monochrome display makes reading data easy.
The Burdick 8300 ECG is a practical, no-nonsense ECG device. Its friendly user interface and clear, readable 5.7-inch monochrome display makes reading data easy.

With the Burdick 8300 ECG, you can:

• Store up to 50 digital ECG records; enjoy on-screen QuickTips
• Save time and reduce errors by transferring patient information and test results quickly
• Enjoy a three-year warranty and service program for worry-free usage


Call your Cardiac Science District Manager or reach us at 800.679.8703 for more information.

www.CardiacScience.com/Burdick8300
CARDIAC SCIENCE 3303 Monte Villa Parkway | | Bothell | WA | Cardiac Science is a global leader in the development, manufacture, and marketing of diagnostic and therapeutic cardiology products and services. We provide a full spectrum of cardiology products and services that help protect hearts and save lives including Devices designed to identify the early stages of heart disease — such as electrocardiographs, cardiac stress testing systems, diagnostic workstations, and Holter monitors; Sophisticated systems for cardiac rehabilitation and cardiology data
Bindex Bindex
Bindex has been proven through research and practice to be an efficient and accurate instrument in osteoporosis diagnostics and evidence based treatment decisions.


Now there's an easy and effective way to screen for osteoporosis. Bindex®.
Osteoporotic fractures account for more hospitalizations than breast cancer, diabetes and myocardial infarction combined.1 Yet while the entire Medicare population of around 60 million is at risk of osteoporosis, only 2.5 million DXA scans are performed annually. Are you screening your Medicare patients?

Why Bindex® is a game-changer in osteoporosis diagnostics.
Bindex® is the world's first evidence-based, point-of-care osteoporosis diagnostics device that provides results comparable to DXA. Portable and lightweight, Bindex® scans in seconds and at a fraction of the cost allowing you to quickly provide much-needed osteoporosis diagnostics for your at-risk patients.



Comparable to DXA: Bindex® is 90% accurate in detecting osteoporosis.
Extensive clinical research has proven Bindex® to be 90% accurate in detecting osteoporosis which means it can replace nearly 70% of DXA scans for patients with suspected osteoporosis.



Fast and effective: A Bindex® scan takes just seconds.
Bindex® measures cortical bone thickness in seconds and instantly analyzes bone density, generating a detailed, easy-to-read report. Just plug the Bindex® device into your laptop and scan.



Easy to use anywhere: Bindex® is lightweight and pocket-sized.
Using safe pulse-echo ultrasound, handheld Bindex® allows you to offer bone density scans on the spot. Its portability makes it easy to use in a wide variety of settings — hospitals, clinics, patients' homes, osteoporosis screening events and more.



Tested, proven and relied on worldwide.
Designed and developed by Bone Index Ltd, a healthcare diagnostics company, Bindex® is FDA-cleared and has been validated in clinical trials with several thousand patients. This revolutionary device has already screened over 1.6 million people in the US, and has 19 global patents in the US, China, Japan and major EU countries.

Now you can be part of the Bindex launch and trial at no cost.
To trial Bindex in your office, visit Bindex.us/launch or call (970)-306-7452.

1 International Osteoporosis Foundation

Bindex 2751 Hennepin Avenue #212 | | Minneapolis | MN | Bindex has been proven through research and practice to be an efficient and accurate instrument in osteoporosis diagnostics and evidence based treatment decisions.
Pronto® MASIMO
Pronto — with rainbow® technology — for noninvasive and quick spot checking of total hemoglobin (SpHb®), SpO2, pulse rate, and perfusion index.


Pronto® Pulse CO-Oximeter® with rainbow® Technology for Noninvasive Spot-Checking of Total Hemoglobin (SpHb®) and SpO2 in a Handheld device.

Featuring Masimo SET® Measure-through Motion and Low Perfusion™ Pulse Oximetry Technology:
  • Helps clinicians monitor more than 100 million patients a year1
  • Used by the top 10 U.S. hospitals listed in the 2017-18 U.S. News and World Report Best Hospitals Honor Roll2


1 Estimate: Masimo data on file.

2 http://health.usnews.com/health-care/best-hospitals/articles/best-hospitals-honor-roll-and-overview

MASIMO 52 Discovery | | Irvine | CA | Masimo is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. A key medical technology innovator, Masimo is responsible for the invention of award-winning noninvasive technologies that are revolutionizing patient monitoring.
Histofreezer ORASURE TECHNOLOGIES, INC.
Histofreezer® Portable Cryosurgical System is a professional-grade product that offers medical professionals an easy and effective method to treat nine different types of skin lesions, including common, plantar and genital warts and other common benign skin lesions.


Histofreezer® Portable Cryosurgical System is a professional-grade product that offers medical professionals an easy and effective method to treat nine different types of skin lesions, including common, plantar and genital warts and other common benign skin lesions. More than 60,000 medical professionals in primary care, internal medicine, podiatry, ob/gyn and dermatology areas of care have either added Histofreezer® to their practice offering or replaced more invasive and less tolerated procedures with the Histofreezer® advantage. Histofreezer® helps medical professionals provide high-level patient care and satisfaction through quick and virtually pain free treatment of these common conditions.

Histofreezer®
  • Clinically proven
    • Resolution rates comparable to liquid nitrogen
  • Patient-friendly
    • Less than one minute procedure
  • asy-to-use
    • Easy 3 step procedure
  • Trusted brand


ORASURE TECHNOLOGIES, INC. 220 East First Street | | Bethlehem | PA | Based in Bethlehem, Pennsylvania, OraSure Technologies develops, manufactures and markets point-of-care, oral fluid specimen collection devices that leverage proprietary oral fluid technologies, diagnostic products, including immunoassays and other in vitro diagnostic tests, and other medical devices.
OraQuick HCV ORASURE TECHNOLOGIES, INC.
The OraQuick® HCV Rapid Antibody Test is the FIRST and ONLY FDA-approved, point of care test for the detection of HCV antibodies. Our simple, CLIA-waived platform enables healthcare providers to deliver an accurate diagnosis in 20 minutes. The test can be completed in 3 simple steps from 5µl of fingerstick or venous whole blood with less than 2 minutes of hands on time.


The OraQuick® HCV Rapid Antibody Test is the FIRST and ONLY FDA-approved, point of care test for the detection of HCV antibodies. Our simple, CLIA-waived platform enables healthcare providers to deliver an accurate diagnosis in 20 minutes. The test can be completed in 3 simple steps from 5µl of fingerstick or venous whole blood with less than 2 minutes of hands on time. It is ideal for testing programs in both clinical and non-clinical settings, as well as outreach events. Examples include urgent care, labor and delivery, laboratories and physician offices

Orasure HCV


OraQuick HCV Rapid Antibody Test
The FIRST and ONLY FDA- approved, CLIA-waived test for HCV antibodies
Accurate
  • >98% accuracy
  • Lab-accurate results

Simple
  • CLIA-waived with 3 simple steps
  • Requires less than 2 minutes of hands on time

Fast
  • 20 minutes from sample to result
  • Immediately link patients to care


ORASURE TECHNOLOGIES, INC. 220 East First Street | | Bethlehem | PA | Based in Bethlehem, Pennsylvania, OraSure Technologies develops, manufactures and markets point-of-care, oral fluid specimen collection devices that leverage proprietary oral fluid technologies, diagnostic products, including immunoassays and other in vitro diagnostic tests, and other medical devices.
OraSure Ora Quick Advance HIV-1/2 ORASURE TECHNOLOGIES, INC.
The OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test is an FDA-approved point of care screening test for use with oral fluid, fingerstick or venous whole blood and plasma. The test delivers lab accurate results within 20 minutes with less than 2 minutes of hands on time. CDC guidelines call for routine testing in all healthcare settings to identify all HIV positive people and connect them to care.


The OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test is an FDA-approved point of care screening test for use with oral fluid, fingerstick or venous whole blood and plasma. The test delivers lab accurate results within 20 minutes with less than 2 minutes of hands on time. CDC guidelines call for routine testing in all healthcare settings to identify all HIV positive people and connect them to care. This simple test is ideal for testing programs in both clinical and non-clinical settings, as well as outreach events. Examples include urgent care, labor and delivery, laboratories and physician offices.

OraQuick HIV-1/2 Antibody Test


OraQuick ADVANCE HIV-1/2 Rapid Antibody Test
The early HIV antibody detection test for recent infection
Sensitivity
  • >99% accuracy
  • Comparable to 3rd generation lab-accurate results including IgM antibody detection

Versatility
  • Multiple specimen types including oral fluid, fingerstick & venipuncture whole blood, and plasma

Reliability
  • Proven performance with over 40 million tests worldwide
  • High positive predictive value; excellent specificity


ORASURE TECHNOLOGIES, INC. 220 East First Street | | Bethlehem | PA | Based in Bethlehem, Pennsylvania, OraSure Technologies develops, manufactures and markets point-of-care, oral fluid specimen collection devices that leverage proprietary oral fluid technologies, diagnostic products, including immunoassays and other in vitro diagnostic tests, and other medical devices.
CoaguChek XS Plus ROCHE DIAGNOSTICS
Smart PT/INR monitoring at the physician's practice. Healthcare professionals can measure a patient's PT/INR value usually in less than 1 minute with a drop of capillary blood (8 µl).


CoaguChek® XS Plus

Simplified testing with enhanced connectivity for professional use
This small, battery-powered, handheld meter is portable and efficient, ideal for mid to high-volume clinical settings. Plus, you can test and treat in one appointment, using the fingerstick test that patients prefer.

Accurate
  • 97% accuracy to lab for confidence in results*
  • Only handheld, CLIA-waived PT/INR monitoring system that neutralizes therapeutic levels of heparin and low molecular weight heparin within a specified range. See package insert for more information.
  • INR corrected for wide range of hematocrit
  • Two levels of built-in, onboard controls within the test chamber — no external QC necessary


Easy to use
  • Test results in about 1 minute with a small 8 µl sample
  • Large top- and side-dosing area enables easy sample application
  • Outside meter blood application — minimizes potential for cross-contamination
  • Calibration information is provided by a code chip included in all strip vials – no manual calibration, pipetting or preparation of reagents are needed.
  • Up to 21-month strip shelf life from date of manufacture — no refrigeration needed
  • Icon-driven, color touchscreen interface


Smart
  • Stores 2,000 patient and 500 optional liquid QC results
  • Ability to denote patient ID in several fields and add comments after results
  • Data storage for up to 60 code chips
  • Bidirectional data transfer with Roche cobas® IT1000 and other industry leading connectivity systems
  • Operator and QC lockout capabilities


*97% correlation with lab results using Dade Innovin reagent on a Sysmex 560 Analyzer. See package insert for more information. CoaguChek XS PT Test [package insert 05967694001(03)]. Indianapolis, Ind.: Roche Diagnostics; 2013

ROCHE DIAGNOSTICS 9115 Hague Road | Bldg. H | Indianapolis | IN | Personalised Helathcare (PHC) is based on the observation that patients with the same diagnosis react to the same treatment in different ways
CoaguChek XS Pro ROCHE DIAGNOSTICS
Healthcare professionals can measure PT/INR values usually in less than 1 minute with a drop of capillary blood (8 µl).
In order to foster compliance and improve workflows, the system allows patient and operator ID identification with its integrated barcode scanner. Connecting the instrument to the institution’s data management system finally assures safe and most efficient patient management.


CoaguChek® XS Pro

Simplified testing, enhanced connectivity and barcode scanning for high-throughput settings
This battery-powered, handheld meter is portable and efficient, ideal for mid- to high-volume clinical settings. The integrated barcode scanner virtually eliminates manual entry errors. Plus, you can test and treat in one appointment, using the fingerstick test that patients prefer.

Accurate
  • 97% accuracy to lab for confidence in results*
  • Neutralizes therapeutic levels of heparin and low molecular weight heparin within a specified range. See package insert for more information.
  • INR corrected for wide range of hematocrit
  • Two levels of built-in, onboard controls within the test chamber — no external QC necessary


Easy to use
  • Test results in about one minute with a small 8 µl sample
  • Large top- and side-dosing area enables easy sample application
  • Outside meter blood application — minimizes potential for cross-contamination
  • Calibration information is provided by a code chip included in all strip vials — no manual calibration, pipetting or preparation of reagents are needed
  • Up to 21-month strip shelf life from date of manufacture — no refrigeration needed
  • Icon-driven, color touchscreen interface


Smart
  • Integrated barcode scanner provides a quick, simple way to capture patient and operator IDs
  • Stores 2,000 patient and 500 optional liquid QC results
  • Ability to denote patient ID in several fields and add comments after results
  • Data storage for up to 60 code chips
  • Bidirectional data transfer with Roche cobas® IT1000 and other industry leading connectivity systems
  • Operator and QC lockout capabilities


*97% correlation with lab results using Dade Innovin reagent on a Sysmex 560 Analyzer. See package insert for more information. CoaguChek XS PT Test [package insert 05967694001(03)]. Indianapolis, Ind.: Roche Diagnostics; 2013

ROCHE DIAGNOSTICS 9115 Hague Road | Bldg. H | Indianapolis | IN | Personalised Helathcare (PHC) is based on the observation that patients with the same diagnosis react to the same treatment in different ways
CoaguChek® XS ROCHE DIAGNOSTICS
Only handheld, CLIA-waived PT/INR monitoring system that neutralizes therapeutic levels of heparin and low molecular weight heparin within a specified range


CoaguChek® XS Meter

Accurate
  • 97% accuracy to lab for confidence in results*
  • Only handheld, CLIA-waived PT/INR monitoring system that neutralizes therapeutic levels of heparin and low molecular weight heparin within a specified range. See package insert for more information.
  • Two levels of built-in, onboard controls within the test chamber


Easy to use
  • Test results in about one minute with a small 8 µl sample
  • Large top- and side-dosing area enables easy sample application
  • Outside meter blood application — minimizes potential for cross-contamination
  • Up to 21-month strip shelf life from date of manufacture — no refrigeration needed


*97% correlation with lab results using Dade Innovin reagent on a Sysmex 560 Analyzer. See package insert for more information. CoaguChek XS PT Test [package insert 05967694001(03)]. Indianopolis, IND.: Roche Diagnostics; 2013

ROCHE DIAGNOSTICS 9115 Hague Road | Bldg. H | Indianapolis | IN | Personalised Helathcare (PHC) is based on the observation that patients with the same diagnosis react to the same treatment in different ways
Accu-Chek Lancets ROCHE DIAGNOSTICS
With Accu-Chek Safe-T-Pro Plus and Accu-Chek Safe-T-Pro Uno lancets, you're able to choose the best lancet for your patients and your staff–improving patient comfort and workflow efficiencies


Accu-Chek Professional Lancing Devices

Choose the lancet that’s right for your clinical needs.
With Accu-Chek Safe-T-Pro Plus and Accu-Chek Safe-T-Pro Uno lancets, you’re able to choose the best lancet for your patients and your staff–improving patient comfort and workflow efficiencies.

The safety, comfort and convenience of Accu-Chek® lancets- available in two great options:

Accu-Chek Safe-T-Pro Plus
Simplify care and inventory with the only multi-depth, single-use professional lancet.
  • 1.3mm, 1.8mm, 2.3mm penetration depths
  • Approved for use on adults, children and neonates
  • 23G retractable needle
  • Single SKU simplifies inventory control


New! Accu-Chek Safe-T-Pro Uno
Improve patient comfort simply, safely and affordably while meeting the need for an adequate blood sample.
  • 1.5mm penetration depth
  • Approved for use on adults, children and neonates
  • 28G retractable needle
  • Single-use professional lancet


For care you can count on, the choice is Accu-Chek.

ROCHE DIAGNOSTICS 9115 Hague Road | Bldg. H | Indianapolis | IN | Personalised Helathcare (PHC) is based on the observation that patients with the same diagnosis react to the same treatment in different ways